BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15820931)

  • 21. Interstitial deletions at the long arm of chromosome 13 may be as common as monosomies in multiple myeloma. A genotypic study.
    Nomdedéu JF; Lasa A; Ubeda J; Saglio G; Bellido M; Casas S; Carnicer MJ; Aventín A; Sureda A; Sierra J; Baiget M
    Haematologica; 2002 Aug; 87(8):828-35. PubMed ID: 12161359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion.
    Sagaster V; Ludwig H; Kaufmann H; Odelga V; Zojer N; Ackermann J; Küenburg E; Wieser R; Zielinski C; Drach J
    Leukemia; 2007 Jan; 21(1):164-8. PubMed ID: 17096015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Genetic abnormalities in multiple myeloma: role in oncogenesis and impact on survival].
    Decaux O; Lodé L; Minvielle S; Avet-Loiseau H
    Rev Med Interne; 2007 Oct; 28(10):677-81. PubMed ID: 17559979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.
    Chang H; Qi X; Jiang A; Xu W; Young T; Reece D
    Bone Marrow Transplant; 2010 Jan; 45(1):117-21. PubMed ID: 19448682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of chromosome 13 status in bone marrow cells of patients with multiple myeloma using combined morphologic and fluorescence in situ hybridization analysis.
    Hardan I; Rothman R; Gelibter A; Cohen N; Shimoni A; Sokolovsky M; Reichart M; Ishoev G; Amariglio N; Rechavi G; Nagler A; Trakhtenbrot L
    Exp Hematol; 2004 Mar; 32(3):254-60. PubMed ID: 15003310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [IgA multiple myeloma with adverse prognostic factors--a case report].
    Kumiega B; Wolska-Smoleń T; Skotnicki AB
    Przegl Lek; 2009; 66(8):459-63. PubMed ID: 20043594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromosome 13 deletion in myeloma.
    Shaughnessy J; Barlogie B
    Curr Top Microbiol Immunol; 1999; 246():199-203. PubMed ID: 10396057
    [No Abstract]   [Full Text] [Related]  

  • 28. [Monoclonal gammopathy--multiple myeloma].
    Dietzfelbinger H
    MMW Fortschr Med; 2005 Jun; 147(24):32-3, 35-6. PubMed ID: 16001531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of standard prognostic factors with the deletion of 13q14 detected by interphase fluorescence in situ hybridization on separated and unseparated bone marrow cells in multiple myeloma].
    Smejkalová J; Vranová V; Oltová A; Kuglík P; Filková H; Heinigová J; Kovárová L; Adam Z; Krejcí M; Pour L; Büchler T; Svobodník A; Vostrejsová S; Kalábová V; Vorlícek J; Penka M; Hájek R
    Cas Lek Cesk; 2005; 144(7):483-8. PubMed ID: 16161543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal gammopathy and multiple myeloma: incidence of chromosomal aneuploidy detected by interphase fluorescence in situ hybridization.
    Cianciulli AM; Coletta AM; Pescatore B; Greco C; Del Monte G; Leonardo C; Venturo I; Gandolfo GM
    Eur J Histochem; 1997; 41 Suppl 2():157-8. PubMed ID: 9859828
    [No Abstract]   [Full Text] [Related]  

  • 31. [The significances of 13q14 deletion for development and prognosis of multiple myeloma].
    Li Q; An G; Li CW; Xu Y; Deng SH; Liu XP; Qi JY; Wang YF; Zou DH; Zhao YZ; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):217-20. PubMed ID: 21569701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of chromosome 13 (13q14) deletion among Sudanese patients with multiple myeloma using a molecular genetics fluorescent in situ hybridization technique (FISH).
    Dowd AA; Homeida S; Elkarem HA
    Malays J Pathol; 2015 Aug; 37(2):95-100. PubMed ID: 26277665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of chromosome 12p deletion in plasma cell dyscrasias.
    Jiang N; Qi C; Yu L; Ning Y; An G; Qiu L; Chang H
    Leuk Res; 2012 Jan; 36(1):32-6. PubMed ID: 21982640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical implications of abnormalities of chromosomes 1 and 13 in multiple myeloma.
    Nakagawa Y; Sawanobori M; Amaya H; Matsuda I; Inoue Y; Suzuki K; Hashimoto S; Kanno K
    Acta Haematol; 2003; 109(3):129-36. PubMed ID: 12714822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of chromosome 13 deletion in plasma cell leukemia by dual-color fluorescence in situ hybridization].
    Xu W; Li JY; Fan L; Chen LJ; Qiu HR; Wang R; Qiao C; Lu H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1261-4. PubMed ID: 19099623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypergranular multiple myeloma with crystalline inclusions in young with 13q deletion.
    Muniswari U; Panigrahi C; Mishra SK; Padhi S
    Indian J Pathol Microbiol; 2024 Apr; 67(2):484-486. PubMed ID: 38394421
    [No Abstract]   [Full Text] [Related]  

  • 37. Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.
    Wu KL; Beverloo B; Lokhorst HM; Segeren CM; van der Holt B; Steijaert MM; Westveer PH; Poddighe PJ; Verhoef GE; Sonneveld P; ;
    Br J Haematol; 2007 Feb; 136(4):615-23. PubMed ID: 17223915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of central nervous system myelomatosis with complex chromosome aberrations].
    Bang HI; Yoo JY; Kim KH; Park R; Shin JW; Choi TY; Lee SC; Park HS; Won JH
    Korean J Lab Med; 2010 Aug; 30(4):334-8. PubMed ID: 20805703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines.
    Maura F; Petljak M; Lionetti M; Cifola I; Liang W; Pinatel E; Alexandrov LB; Fullam A; Martincorena I; Dawson KJ; Angelopoulos N; Samur MK; Szalat R; Zamora J; Tarpey P; Davies H; Corradini P; Anderson KC; Minvielle S; Neri A; Avet-Loiseau H; Keats J; Campbell PJ; Munshi NC; Bolli N
    Leukemia; 2018 Apr; 32(4):1044-1048. PubMed ID: 29209044
    [No Abstract]   [Full Text] [Related]  

  • 40. Delineation of the minimal region of loss at 13q14 in multiple myeloma.
    Elnenaei MO; Hamoudi RA; Swansbury J; Gruszka-Westwood AM; Brito-Babapulle V; Matutes E; Catovsky D
    Genes Chromosomes Cancer; 2003 Jan; 36(1):99-106. PubMed ID: 12461754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.